Mobia Medical Inc. has priced its initial public offering at $15.00 per share, offering 10 million shares and targeting roughly $150 million in gross proceeds before underwriting discounts and other expenses, the company said.
The firm anticipates its common stock will start trading on the Nasdaq Global Select Market under the ticker symbol "MOBI" on May 8, 2026. The transaction is expected to formally close on May 11, 2026, contingent on customary closing conditions.
Under the terms of the offering, Mobia Medical has granted the underwriting syndicate a 30-day option to buy up to an additional 1.5 million shares at the initial offering price, less underwriting discounts and commissions. That option would allow underwriters to increase the total number of shares sold in the IPO within the prescribed period.
Leading the bookrunning roles for the offering are BofA Securities, J.P. Morgan and Goldman Sachs & Co. LLC. BTIG is listed as a passive bookrunner while Wolfe | Nomura Alliance is acting as a manager for the deal.
Headquartered in Austin, Texas, Mobia Medical develops medical devices focused on stroke rehabilitation. Its Vivistim Paired VNS System is an FDA-approved implantable device intended to improve upper limb function in people who survived chronic ischemic stroke and who have moderate to severe impairments of the upper extremity.
The company filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission in connection with the offering; that filing became effective on May 7, 2026, according to the company’s statement.
Investors and market participants should note the offering size, pricing and the underwriters’ overallotment option as they assess the immediate market supply of shares once trading begins. The company’s oversight and disclosure around the S-1 and its timing indicate the procedural steps completed ahead of the expected Nasdaq listing.
Offering snapshot
- Shares offered: 10,000,000
- Price per share: $15.00
- Gross proceeds (approximate): $150 million before underwriting discounts and other expenses
- Overallotment option: Up to 1,500,000 additional shares, exercisable for 30 days
- Expected Nasdaq trading date: May 8, 2026 (ticker: MOBI)
- Expected close date: May 11, 2026, subject to customary closing conditions